Duration of fasting before taking lapatinib is associated with skin toxicity in neoadjuvant treatment of HER2 positive breast cancer: A cohort study from JBCRG-16/Neo-LaTH

Category Primary study
JournalCancer Research
Year 2017
This article has no abstract
Epistemonikos ID: 1a5ed1c5126fe49572cdb1832994694540f8a792
First added on: Feb 08, 2025